| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(82)90024-8 |
| P698 | PubMed publication ID | 7201234 |
| P2093 | author name string | G V Naccarelli | |
| D P Zipes | |||
| E N Prystowsky | |||
| J J Heger | |||
| W M Jackman | |||
| G T Rahilly | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ventricular tachycardia | Q56002 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 165-171 | |
| P577 | publication date | 1982-07-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease | |
| P478 | volume | 50 |
| Q38678347 | Acute and semiacute management of cardiac arrest. |
| Q36832205 | Amiodarone Therapy Guided by Electrophysiologic Testing: An Update |
| Q44454555 | Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. |
| Q69960739 | Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study |
| Q40169647 | Antiarrhythmic treatment: An overview |
| Q93649184 | Cardiac arrhythmias in patients with surgical repair of Ebstein's anomaly |
| Q70649495 | Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin |
| Q70806175 | Clinical electrophysiology of ventricular tachycardia |
| Q33169536 | Clinical intracardiac electrophysiologic testing: technique, diagnostic indications, and therapeutic uses |
| Q72713583 | Definition of benign versus malignant ventricular arrhythmias: Targets for treatment |
| Q52664858 | Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias. |
| Q41227083 | Effect of acute hemodynamic decompensation on electrical inducibility of ventricular arrhythmias in patients with dilated cardiomyopathy and complex nonsustained ventricular arrhythmias |
| Q69621286 | Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram |
| Q41448767 | Electrophysiologic testing in patients with ventricular tachycardia: past performance and future expectations |
| Q73702600 | Endomyocardial biopsy findings in patients with atrioventricular block in the absence of apparent heart disease |
| Q33172607 | Evaluation and treatment of survivors of sudden cardiac death or nonbradycardic syncope unrelated to coronary artery disease. |
| Q70654290 | Evaluation of the patient with syncope |
| Q70654270 | Evaluation of the patient with wide QRS tachycardia |
| Q42250352 | Facilitation of ventricular tachyarrhythmia induction by isoproterenol |
| Q39743123 | General concepts and mechanisms of ventricular tachycardia. |
| Q51641248 | Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. |
| Q70880364 | Implantable cardioverter defibrillator: use in patients with no symptoms and at high risk |
| Q33169695 | Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death |
| Q69495372 | Management of arrhythmias in heart failure |
| Q34085399 | Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators |
| Q24197872 | Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy |
| Q40156966 | Pathophysiology of arrhythmias: Clinical electrophysiology |
| Q69055228 | Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: influence of the underlying heart disease on the results of electrophysiologic testing |
| Q70032014 | Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: patients with clinical sustained ventricular tachyarrhythmias |
| Q46138335 | Selection of patients for programmed ventricular stimulation: A clinical decision-marking model based on multivariate analysis of clinical variables |
| Q68495454 | Significance of ventricular tachyarrhythmias complicating cardiac catheterization: a CASS Registry Study |
| Q71072136 | Subendocardial resection for refractory ventricular tachycardia: effects on ambulatory electrocardiogram, programmed stimulation and ejection fraction, and relation to outcome |
| Q33591383 | Sudden death in dilated cardiomyopathy |
| Q58011071 | The long QT syndrome |
| Q93571884 | Treatment of ventricular arrhythmia. Applications and limitations of noninvasive vs invasive approach |
| Q34118920 | Unexpected myocardial disease in patients with life threatening arrhythmias |
| Q69653968 | Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy |
| Q71643157 | Ventricular Arrhythmia Factors in Mitral Valve Prolapse |
| Q40075874 | Ventricular Premature Beats, Ventricular Tachycardia, and Sudden Cardiac Death: Identification of Patients and Drug Treatment |
| Q33172115 | Ventricular Tachyarrhythmias in the Long QT Syndromes |
| Q40109375 | Ventricular Tachycardia-1983 |
| Q36303988 | Ventricular arrhythmia in congestive heart failure |
| Q72347608 | Ventricular arrhythmias in heart failure |
| Q58844535 | Ventricular tachycardia in Chagas' disease |
| Q37041247 | Wide Complex Tachycardias: Differential Diagnosis and Management |
Search more.